Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGS in Peripheral T-Cell Non-Hodgkin's Lymphoma
NCT00109928Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2005
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, etoposide, gemcitabine, methylprednisolone in peripheral T-cell non-Hodgkin lymphoma (PTCL), sponsored by SWOG Cancer Research Network. Started Sep 2005; status: completed.
02
Drugs
cisplatinetoposidegemcitabinemethylprednisolone
03
Conditions
peripheral T-cell non-Hodgkin lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00109928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109928.